19 results
DEFA14A
APGE
Apogee Therapeutics, Inc.
28 May 24
Additional proxy soliciting materials
7:36am
and Corporate Governance Committee of the Board.
Dr. Bollinger, age 60, is a pediatric trained physician with over 30 years of experience in drug
8-K
APGE
Apogee Therapeutics, Inc.
28 May 24
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
7:35am
is duly elected and qualified, effective May 28, 2024. The Board also appointed Dr. Bollinger to serve as a member of the Nominating and Corporate … Governance Committee of the Board.
Dr. Bollinger, age 60, is a pediatric trained physician with over 30 years of experience in drug development
DEF 14A
APGE
Apogee Therapeutics, Inc.
24 Apr 24
Definitive proxy
4:15pm
: APPROVAL OF OPTION GRANT TO A DIRECTOR
CORPORATE GOVERNANCE
EXECUTIVE OFFICERS
EXECUTIVE COMPENSATION
CERTAIN INFORMATION ABOUT OUR COMMON STOCK … Board of Directors, corporate governance practices and executive compensation program and equity compensation utilization, are forward-looking
10-K
gbq1r7
5 Mar 24
Annual report
6:15am
DRS
fg6cv jnxi
9 Feb 24
Draft registration statement
12:00am
10-Q
EX-3.2
qkw oe8wm8t
28 Aug 23
Quarterly report
8:00am
10-Q
39y5g 1n7l
28 Aug 23
Quarterly report
8:00am
8-K
EX-99.1
tsg bev6ba
28 Aug 23
Apogee Highlights Corporate Progress and Reports Second Quarter 2023 Financial Results
7:35am
8-K
w64dh2gpux8 w6iwgrh
21 Aug 23
Departure of Directors or Certain Officers
7:35am
424B4
7mntqkr
17 Jul 23
Prospectus supplement with pricing info
4:08pm
S-1/A
EX-3.5
gvep0aqierirr uwbk8
3 Jul 23
IPO registration (amended)
4:44pm
S-1
39wryjxg85cocd2cu5
22 Jun 23
IPO registration
4:19pm
S-1
EX-3.3
qo3gmr5jj19mhp3cb
22 Jun 23
IPO registration
4:19pm
DRS/A
fhr7x4
5 Jun 23
Draft registration statement (amended)
12:00am
DRS
0zms9s4f4pkm 1j
28 Apr 23
Draft registration statement
12:00am
- Prev
- 1
- Next